The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease
- 16 August 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 328 (3), 314-318
- https://doi.org/10.1016/s0304-3940(02)00553-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Study of the Association between Alzheimer’s Disease and Angiotensin-Converting Enzyme Gene Polymorphism Using DNA from LymphocytesEuropean Neurology, 2002
- Angiotensin I converting enzyme polymorphism in humans with age-associated memory impairment: relationship with cognitive performanceNeuroscience Letters, 2000
- Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's diseaseNeuroscience Letters, 2000
- Association between angiotensin-converting enzyme and Alzheimer disease.Archives of Neurology, 2000
- Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1999
- ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer’s DementiaStroke, 1998
- The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairmentNeuroscience Letters, 1996
- Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disordersEuropean Journal of Pharmacology, 1996
- Angiofensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's diseaseEuropean Journal of Pharmacology, 1991
- Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical AreasJournal of Neurochemistry, 1982